PTK7 and liposarcoma: Data reported in the literature in some other malignancies, including liposarcoma, oesophageal squamous cell carcinoma and invasive cholangiocarcinoma [22,25,27], are also consistent with a similar adverse impact of PTK7 expression on clinical outcome.